MedPath

ANDROGEL

ANDROGEL

Approved
DIN Number

02249499

Drug Class

Human

Market Date

Sep 20, 2004

Company
HC

BGP Pharma ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02249499
AIG Number0106405003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03BA03 TESTOSTERONE
Product Specifications
Dosage FormGel
Route of AdministrationTransdermal
AHFS Classification68:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TESTOSTERONEActive
Strength: 12.5 MG / ACT
Monograph: TESTOSTERONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.